Functional food and beverage company appoints seasoned investor with three decades of Wall Street experience to drive strategic growth initiatives

Glucose Health, Inc. (OTC: GLUC), a specialized functional food and beverage company focused on addressing obesity and diabetes through innovative products, has announced the appointment of Christopher J. Jemapete to its Board of Directors, effective October 29, 2025.

The appointment represents a strategic move to strengthen the company's leadership as it seeks to expand its market presence in the growing functional foods sector. Jemapete, who has been a strategic investor in Glucose Health since 2017, brings extensive financial services expertise and a deep understanding of the company's mission and market potential.

Extensive Financial Services Background

Jemapete's appointment leverages his impressive 30-year career in financial services and securities, including senior positions at some of Wall Street's most prominent firms. His experience spans roles at E.F. Hutton, Shearson Lehman Brothers, and Fidelity Investments, before concluding his corporate career at ALPS Distributors, Inc. in Denver, Colorado, where he worked until his retirement in 2010.

Since retirement, Jemapete has focused on identifying and supporting investment opportunities in the micro-cap equity sector, developing specialized expertise in capital formation, financing structures, and strategic growth execution for emerging companies.

Proven Commitment to Company Growth

As one of Glucose Health's earliest strategic investors, Jemapete has demonstrated unwavering commitment to the company's mission. He has participated in every private placement offering since 2019, playing a crucial role in raising over $2 million in capital to support the company's development and market expansion.

The company's flagship products, GLUCODOWN® and FIBER UP®, have already established a strong retail distribution network through major partners including Amazon and two of the largest brick-and-mortar pharmacy chains in the United States.

Strategic Vision for Growth

Commenting on his appointment and the company's future direction, Jemapete emphasized the importance of adequate capitalization in executing Glucose Health's strategic business plan. "The Company has already established a robust retail distribution network for its flagship products through major partners," he stated. "Our focus moving forward must be to build upon this foundation to drive meaningful revenue growth and enhance shareholder value."

His strategic priorities align with the growing market demand for functional foods and beverages that address specific health concerns, particularly in the diabetes and obesity management sectors.

The appointment comes at a time when the functional foods and beverages market is experiencing significant growth, driven by increasing consumer awareness of health and wellness. Companies like Glucose Health, which develop products specifically targeting health conditions such as diabetes and obesity, are well-positioned to capitalize on this trend.

Jemapete's educational background includes a Bachelor of Science degree in Marketing from Fairfield University and certification as a Certified Financial Planner from Adelphi University, providing him with both the marketing insight and financial acumen necessary to guide the company's strategic development.

The strengthening of Glucose Health's board with Jemapete's appointment signals the company's commitment to professional governance and strategic growth as it continues to develop and market functional food and beverage solutions for health-conscious consumers.